Hartmann LC - Search Results

1

Current management strategies for ovarian cancer.

Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Aletti GD, et al. Among authors: hartmann lc. Mayo Clin Proc. 2007 Jun;82(6):751-70. doi: 10.4065/82.6.751. Mayo Clin Proc. 2007. PMID: 17550756 Review.

2

Elevated fibroblast growth factor 23 in women with malignant ovarian tumors.

Tebben PJ, Kalli KR, Cliby WA, Hartmann LC, Grande JP, Singh RJ, Kumar R. Tebben PJ, et al. Among authors: hartmann lc. Mayo Clin Proc. 2005 Jun;80(6):745-51. doi: 10.1016/S0025-6196(11)61528-0. Mayo Clin Proc. 2005. PMID: 15948297

3

Ovarian cancer care: it's time for "personalized" approaches.

Aletti GD, Hartmann LC. Aletti GD, et al. Among authors: hartmann lc. Oncology (Williston Park). 2010 Jul;24(8):728, 736. Oncology (Williston Park). 2010. PMID: 20718252 No abstract available.

4

From randomized trial to practice: single institution experience using the GOG 172 i.p. chemotherapy regimen for ovarian cancer.

Aletti GD, Nordquist D, Hartmann L, Gallenberg M, Long HJ, Cliby WA. Aletti GD, et al. Ann Oncol. 2010 Sep;21(9):1772-1778. doi: 10.1093/annonc/mdq025. Epub 2010 Feb 5. Ann Oncol. 2010. PMID: 20139154 Free article. Clinical Trial.

5

Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer.

Jatoi A, Podratz KC, Gill P, Hartmann LC. Jatoi A, et al. Among authors: hartmann lc. J Support Oncol. 2004 Jul-Aug;2(4):323-34; discussion 334-7. J Support Oncol. 2004. PMID: 15357517 Review.

6

Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.

Hartmann LC, Lu KH, Linette GP, Cliby WA, Kalli KR, Gershenson D, Bast RC, Stec J, Iartchouk N, Smith DI, Ross JS, Hoersch S, Shridhar V, Lillie J, Kaufmann SH, Clark EA, Damokosh AI. Hartmann LC, et al. Clin Cancer Res. 2005 Mar 15;11(6):2149-55. doi: 10.1158/1078-0432.CCR-04-1673. Clin Cancer Res. 2005. PMID: 15788660

7

Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity.

Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, Kalli KR, Staub J, Ehrmann M, Cliby WA, Lee YK, Bible KC, Hartmann LC, Kaufmann SH, Shridhar V. Chien J, et al. Among authors: hartmann lc. J Clin Invest. 2006 Jul;116(7):1994-2004. doi: 10.1172/JCI27698. Epub 2006 Jun 8. J Clin Invest. 2006. PMID: 16767218 Free PMC article.

8

Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer.

Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Chien JR, et al. Among authors: hartmann lc. J Cell Biochem. 2007 Dec 1;102(5):1117-29. doi: 10.1002/jcb.21552. J Cell Biochem. 2007. PMID: 17879946 Review.

9

Inherited determinants of ovarian cancer survival.

Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, Lancaster JM, Olson JE, Schildkraut JM, Cunningham JM, Hartmann LC. Goode EL, et al. Among authors: hartmann lc. Clin Cancer Res. 2010 Feb 1;16(3):995-1007. doi: 10.1158/1078-0432.CCR-09-2553. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103664 Free PMC article.

10

Nutritional status, CT body composition measures and survival in ovarian cancer.

Torres ML, Hartmann LC, Cliby WA, Kalli KR, Young PM, Weaver AL, Langstraat CL, Jatoi A, Kumar S, Mariani A. Torres ML, et al. Among authors: hartmann lc. Gynecol Oncol. 2013 Jun;129(3):548-53. doi: 10.1016/j.ygyno.2013.03.003. Epub 2013 Mar 21. Gynecol Oncol. 2013. PMID: 23523419

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

242 results

Search Page